News & Events
In the News
Detail page for Safety First: Potential Heart Health Risks of MicrodosingSafety First: Potential Heart Health Risks of Microdosing
Given the current evidence for psychedelic “microdosing,” the risks may outweigh the benefits for many people. This is because there is compelling theoretical evidence to suggest prolonged and repeated microdosing may cause valvular heart disease (VHD), and only weak survey evidence that it provides the benefits microdosers typically seek, such as enhanced cognition, or relief from depression and anxiety.
Detail page for Mixing Antidepressants and PsychedelicsMixing Antidepressants and Psychedelics
As a teenager in the 1990s, Kelan Thomas started reading Aldous Huxley. The novelist is credited with helping to coin the term “psychedelic,” and his books and essays asked big questions about mysticism, dystopia, and perception. Thomas went on to study pharmacogenetics, a field that investigates how genetics influence drug response. He’s now an associate professor of pharmacy sciences at Touro University in Vallejo, California.
Detail page for Ozempic In A Pill: Could Higher Doses Improve Blood Sugar, Weight Loss?Ozempic In A Pill: Could Higher Doses Improve Blood Sugar, Weight Loss?
Dr. Jay Shubrook, professor of the Primary Care Department at Touro University, California, noted that all GLP-1 drugs, as pharmacological agents, can have side effects.
Detail page for Microneedles Show Promise For Future TherapiesMicroneedles Show Promise For Future Therapies
“The collection of interstitial fluid through microneedles provides ample diagnostic potential, including the assessment of immune response,” says Dr Kevin Ita, professor of Pharmaceutics and Drug Delivery at Touro University California.
Detail page for Microdosing psychedelics has benefits, users say. Science isn’t convinced.Microdosing psychedelics has benefits, users say. Science isn’t convinced.
These drugs “consistently show VHD in about 25 percent of those exposed, which is an outrageously high incidence rate for a potentially irreversible valvular heart disease that may require surgery or cause death compared to other drugs with long-term adverse effects,” said Thomas, who also is an associate professor in pharmacy at Touro University California.
Detail page for For Patients With Fatty Liver: Time to Make a DealFor Patients With Fatty Liver: Time to Make a Deal
"Weight loss is the treatment; you negotiate with your patients the method,' said Jay Shubrook, DO, who specializes in metabolic disorders at Touro University California College of Osteopathic Medicine in Vallejo.
Detail page for Activity 'Snacks' Could Lower Blood Sugar, Complication Risk In Type 1 DiabetesActivity 'Snacks' Could Lower Blood Sugar, Complication Risk In Type 1 Diabetes
“This study is interesting,” commented Dr. Sumera Ahmed, an assistant professor at the College of Osteopathic Medicine at Touro University California, who was not involved in the study.
Detail page for Targeted Strategies in Lipid-Lowering TherapyTargeted Strategies in Lipid-Lowering Therapy
Where Do We Stand Now? Jay H. Shubrook, DO, FAAFP, FACOFP
Detail page for Touro Announces Graduation Ceremonies ScheduleTouro Announces Graduation Ceremonies Schedule
Touro University California announces graduation ceremonies schedule for the class of 2023.